Form D

View Original Filing

Notice of Exempt Offering of Securities

Item 1. Issuer's Identity

Name of Issuer:
ZYNERBA PHARMECEUTICALS, INC.
Jurisdiction of Incorporation/Organization
DE
Year of Incorporation/Organization
Over Five Years Ago

Previous Name(s)

  • ALLTRANZ, INC.
Entity Type
CORPORATION

Item 2 Issuer Principal Place of Business and Contact Information

170 N. RADNOR-CHESTER ROAD
SUITE 350
RADNOR, PA 19087
Phone Number: subscription required

Item 3. Related Persons

Name
ARMANDO ANINDO
Address
subscription required
Relationship(s)
  • EXECUTIVE OFFICER
  • DIRECTOR
Clarification of Response

Item 3. Related Persons

Name
STEVEN GAILAR
Address
subscription required
Relationship(s)
  • DIRECTOR
Clarification of Response

Item 3. Related Persons

Name
PHILIP WAGENHEIM
Address
subscription required
Relationship(s)
  • DIRECTOR
Clarification of Response

Item 3. Related Persons

Name
TERRI B. SEBREE
Address
subscription required
Relationship(s)
  • EXECUTIVE OFFICER
Clarification of Response

Item 3. Related Persons

Name
SUZANNE HANLON
Address
subscription required
Relationship(s)
  • EXECUTIVE OFFICER
Clarification of Response

Item 4. Industry Group

PHARMACEUTICALS

Item 5. Issuer Size

Revenue Range (for issuer not specifying "hedge" or "other investment" fund in Item 4 above)
DECLINE TO DISCLOSE

Item 6. Federal Exemptions and Exclusions Claimed

Item 7. Type of Filing

New Notice
Date of First Sale in this Offering:
09/24/2014

Item 8. Duration of Offering

Does the issuer intend this offering to last more than one year?
No

Item 9. Type(s) of Securities Offered

  • Equity
  • Option, Warrant or Other Right to Acquire Another Security
  • Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security

Item 10. Business Combination Transaction

Is this offering being made in connection with a business combination transaction, such as a merger, acquisition or exchange offer?
No
Clarification of Response

Item 11. Minimum Investment

Minimum Investment accepted from any outside investor
0

Item 12. Sales Compensation

Recipient
BROADBAND CAPITAL MANAGEMENT, LLC
Recipient CRD Number
48001
(Associated) Broker or Dealer)
NONE
(Associated) Broker or Dealer CRD Number
NONE
Address
712 FIFTH AVENUE
22ND FLOOR
NEW YORK, NY 10019
States of Solicitation
  • CA
  • CO
  • CT
  • FL
  • MD
  • NY
  • NC
  • PA
  • SC
  • WI

Item 13. Offering and Sales Amounts

Total Offering Amount
13000000
Total Amount Sold
7309180
Total Remaining to be Sold
5690820
Clarification of Response

Item 14. Investors

Securities in the offering have been or may be sold to persons who do not qualify as accredited investors,
Number of non-accredited investors who already have invested in the offering:
Total number of investors who already have invested in the offering:
30

Item 15. Sales Commissions and Finders' Fees Expenses

Sales Commissions:
0.0
Finders' Fees
0.0
Clarification of Response
THE PLACEMENT AGENT WAS REIMBURSED FOR EXPENSES INCURRED IN CONNECTION WITH THE OFFERING AND RECEIVED CASH AND STOCK FOR SERVICES TO THE COMPANY INCLUDING FINANCIAL ADVISORY, MANAGEMENT CONSULTING AND EXECUTIVE RECRUITMENT.

Item 16. Use of Proceeds

Provide the amount of the gross proceeds of the offering that has been or is proposed to be used for payments to any of the persons required to be named as executive officers,directors or promoters in response to Item 3 above.
0.0
Clarification of Response
A PORTION OF THE PROCEEDS WILL BE USED TO PAY EXPENSES AND FEES DISCLOSED IN ITEM 15 TO THE PLACEMENT AGENT, WHICH IS ASSOCIATED WITH ONE OF THE COMPANY'S DIRECTORS.

Signature and Submission

Issuer Name
ZYNERBA PHARMECEUTICALS, INC.
Issuer Signature
ARMANDO ANIDO
Signer Name
ARMANDO ANIDO
Signer Title
CHAIRMAN OF THE BOARD AND CHIEF EXECUTIVE OFFICER
Signature Date
10/09/2014
WhaleWisdom Logo

Elevate your investments